The Good, the Bad, and the Ugly of Interleukin-6 Signaling

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2014 May 23

PMID 24850773

Citations 68

Authors

Jose J Fuster

Kenneth Walsh

Affiliations

Soon will be listed here.

Citing Articles

Unveiling the anti-inflammatory mechanism of exogenous hydrogen sulfide in Kawasaki disease based on network pharmacology and experimental validation.

Yu L, Luo Q, Rao X, Xiao X, Wang P Sci Rep. 2025; 15(1):7410.

PMID: 40033067 PMC: 11876624. DOI: 10.1038/s41598-025-91998-7.

Molecular evidence of the inhibitory potential of melatonin against sodium arsenite toxicity.

Farhadi R, Daniali M, Baeeri M, Khorasani R, Haghi-Aminjan H, Gholami M Heliyon. 2025; 11(3):e42113.

PMID: 39916822 PMC: 11799970. DOI: 10.1016/j.heliyon.2025.e42113.

Interactions of human milk oligosaccharides with the immune system.

Slater A, Hickey R, Davey G Front Immunol. 2025; 15:1523829.

PMID: 39877362 PMC: 11772441. DOI: 10.3389/fimmu.2024.1523829.

Human 3D Lung Cancer Tissue Photothermal Therapy Using Zn- and Co-Doped Magnetite Nanoparticles.

de Moraes E, Siqueira Furtuoso Rodrigues M, de Menezes R, Vinicius-Araujo M, Valadares M, Bakuzis A ACS Biomater Sci Eng. 2025; 11(2):1084-1095.

PMID: 39853243 PMC: 11815621. DOI: 10.1021/acsbiomaterials.4c01901.

Serotonin receptor 5-HT7 modulates inflammatory-associated functions of macrophages.

Bahr F, Muller F, Kasten M, Benen N, Sieve I, Scherr M Cell Mol Life Sci. 2025; 82(1):51.

PMID: 39833622 PMC: 11747067. DOI: 10.1007/s00018-024-05570-z.

References

Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei X . IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998; 101(2):311-20. PMC: 508569. DOI: 10.1172/JCI1368. View

Sabio G, Das M, Mora A, Zhang Z, Jun J, Ko H . A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science. 2008; 322(5907):1539-43. PMC: 2643026. DOI: 10.1126/science.1160794. View

Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T . Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 1994; 368(6469):339-42. DOI: 10.1038/368339a0. View

Rabe B, Chalaris A, May U, Waetzig G, Seegert D, Williams A . Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood. 2007; 111(3):1021-8. DOI: 10.1182/blood-2007-07-102137. View

Mauer J, Chaurasia B, Goldau J, Vogt M, Ruud J, Nguyen K . Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol. 2014; 15(5):423-30. PMC: 4161471. DOI: 10.1038/ni.2865. View

Schuett H, Oestreich R, Waetzig G, Annema W, Luchtefeld M, Hillmer A . Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2011; 32(2):281-90. DOI: 10.1161/ATVBAHA.111.229435. View

Elhage R, Clamens S, Besnard S, Mallat Z, Tedgui A, Arnal J . Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. Atherosclerosis. 2001; 156(2):315-20. DOI: 10.1016/s0021-9150(00)00682-1. View

Schieffer B, Selle T, Hilfiker A, Hilfiker-Kleiner D, Grote K, Tietge U . Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation. 2004; 110(22):3493-500. DOI: 10.1161/01.CIR.0000148135.08582.97. View

Senn J, Klover P, Nowak I, Mooney R . Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 2002; 51(12):3391-9. DOI: 10.2337/diabetes.51.12.3391. View

10.

Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D . IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol. 2003; 4(6):551-6. DOI: 10.1038/ni938. View

11.

Carey A, Steinberg G, Macaulay S, Thomas W, Holmes A, Ramm G . Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes. 2006; 55(10):2688-97. DOI: 10.2337/db05-1404. View

12.

Pedersen B, Fischer C . Beneficial health effects of exercise--the role of IL-6 as a myokine. Trends Pharmacol Sci. 2007; 28(4):152-6. DOI: 10.1016/j.tips.2007.02.002. View

13.

McLoughlin R, Jenkins B, Grail D, Williams A, Fielding C, Parker C . IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc Natl Acad Sci U S A. 2005; 102(27):9589-94. PMC: 1172246. DOI: 10.1073/pnas.0501794102. View

14.

Sarwar N, Butterworth A, Freitag D, Gregson J, Willeit P, Gorman D . Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012; 379(9822):1205-13. PMC: 3316940. DOI: 10.1016/S0140-6736(11)61931-4. View

15.

Huber S, Sakkinen P, Conze D, Hardin N, Tracy R . Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 1999; 19(10):2364-7. DOI: 10.1161/01.atv.19.10.2364. View

16.

Yuen D, Dwyer R, Matthews V, Zhang L, Drew B, Neill B . Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-alpha expression. Diabetes. 2009; 58(5):1086-95. PMC: 2671037. DOI: 10.2337/db08-0775. View